Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.

Dunnwald LK, Rossing MA, Li CI. · 2007

Read Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. by Dunnwald LK, Rossing MA, Li CI. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1851385.txt.

Description

Dunnwald, Rossing and Li charted in 2007 how hormone receptor status shapes breast cancer survival. Tumors that carry estrogen or progesterone receptors respond to hormone signals and usually carry a better outlook. Few studies had checked whether survival gaps change across age, race, or tumor traits.

They used registry data on 155,175 women aged 30 or older diagnosed with invasive breast cancer between 1990 and 2001. Compared with tumors positive for both receptors, every other group faced higher death risk in every subgroup examined. Tumors positive only for estrogen carried about 1.2 to 1.5 times the risk. Tumors positive only for progesterone fell in between. Those negative for both receptors carried about 2.1 to 2.6 times the risk, and the gaps widened further in some tumor categories.

Catalog record

CREATORDunnwald LK, Rossing MA, Li CI.
YEAR2007
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC1851385

Browse the full library · About the Tower of Babel